Redcare Pharmacy's net debt stood at EUR 69.8 mil and accounted for 13.7% of equity at the end of 2024. The ratio is up 7.60 pp compared to the previous year.
Historically, the firm’s net debt to equity reached a high of 20.0% in 2022 and a low of -144% in 2015 between 2013 and 2024. The average for the last five years was 1.44%.
Net debt to EBITDA was calculated at 2.39x at the end of the year. ERROR: A non-numeric value encountered That is up from -1.94x seen in 2019. The ratio reached a high of 6.99x in 2016 and a low of -5.92x in 2020.
The company’s cost of funding amounted to 0.552% in 2024, down which is above the 5-year of 0.632%. Funding costs have “eaten” some 3.49% of the operating profit generated in 2019.
You can see all the company’s data at Redcare Pharmacy profile, or you can download a report on the company in the report section.
Helgi Library 
